MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use

Details for Australian Patent Application No. 2003217606 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 60/358,824 05.12.02 US; 60/383,068 23.05.02 US

5 February 2004 Application Open to Public Inspection

Published as AU-B-2003217606

18 November 2004 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Sep 2004

27 January 2005 Section 223 Application Received

Institute of Virology An application to extend the time from 03 Dec 2003 to 03 Nov 2004 in which to comply with Section 6(c) has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

17 March 2005 Section 223 Application Allowed

Institute of Virology The time in which to comply with Section 6(c) has been extended to 03 Nov 2004. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

22 November 2007 Application Accepted

Published as AU-B-2003217606

20 December 2007 Corrigenda

Applications Accepted - Name Index Under the name Institute of Virology, Application No. 2003217606, under INID (72), correct the invention title to read MN/ CA IX-specific monoclonal antibodies generated from MN/CA IXdeficient mice methods of use and under INID (30), correct the priority data to read 60/358,824 US 21 Feb 2002, 60/431,499 US 5 Dec 2002 and 60/383,068 US 23 May 2002

10 January 2008 Corrigenda

Applications Accepted - Name Index Under the name Institute of Virology, Application No. 2003217606, under INID (54), correct the invention title to read Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/nue/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes

24 January 2008 Corrigenda

Applications Accepted - Name Index Under the name Institute of Virology, Application No. 2003217606, under INID (54), correct the invention title to read Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/neu/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes

13 March 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 10 Jan 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

20 March 2008 Standard Patent Sealed

17 July 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 10 Jan 2008

25 September 2008 Corrigenda

Applications Accepted - Name Index Under the Name Institute of Virology, Application No. 2003217606, Under INID (22), correct the date of filing application to 21 February 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.